Professional Documents
Culture Documents
11(09), 1112-1115
RESEARCH ARTICLE
THE POTENTIAL OF AI IN HEALTHCARE
Piyush Gupta
Student, Bal Bharati Public School.
……………………………………………………………………………………………………....
Manuscript Info Abstract
……………………. ………………………………………………………………
Manuscript History The rise of artificial intelligence in the past decade has been on an
Received: 28 July 2023 exponential slope, with recent advancements breaking through what
Final Accepted: 31 August 2023 was seen as a roadblock. With graphs leading up to even more
Published: September 2023 advancements, we need to ponder the possibilities of it affecting
different aspects of studies, especially in the field of medicine. The
Key words:-
Artificial Intelligence, Ethical previous studies did so in a fragmented way, under a more specialised
Challenges, Patient Outcomes, Data eye. This study aims to compile some of the earlier studies and give an
Protection, Responsible Implementation overview of the potential of AI in healthcare. This research delves into
the transformative impact of artificial intelligence (AI) on healthcare
delivery. AI enhances diagnostic accuracy through rapid analysis of
medical images but faces ethical and data challenges. It empowers
personalised medicine, improves patient outcomes, and reduces side
effects, especially in resource-constrained settings. Predictive analytics
enables early interventions and minimises hospital readmissions, yet
algorithmic biases need addressing. AI expedites medical research by
extracting insights from vast datasets. Despite its potential, AI
integration requires addressing patient acceptance, algorithmic bias,
regulatory compliance, and data protection while emphasising ethical
considerations for responsible implementation in healthcare.
According to Joseph Waller et al. (2022), artificial intelligence’s implementation in diagnostic and interventional
radiology can improve image analysis as well as aid in diagnosis and the suggestion of clinical intervention, trainee
1112
Corresponding Author:- Piyush Gupta
Address:- Student, Bal Bharati Public School.
ISSN: 2320-5407 Int. J. Adv. Res. 11(09), 1112-1115
education, and clinical predictive modeling. Although the use of such methods can lead to some problems, like
ethical challenges and the requirement of large-scale datasets with appropriate labelling of factors like region, age,
etc., In addition, the training data should represent the population where the machine learning application would be
applicable. And lastly, machines are challenging to utilise in medical imaging since they do not provide a statistical
justification when explaining the task's goal.
Nicholas J. Schork et al. (2022) said that researchers now need to devise methods for analyzing, integrating, and
interpreting the enormous amounts of data generated by high-throughput, data-intensive biomedical research assays
and technologies, such as DNA sequencing, imaging protocols, and wireless health monitoring devices. Although a
wide range of statistical approaches have been developed to handle the "big data" generated by these tests, past
experiences with their use indicate that they may be especially suitable.Humans differ greatly at the genetic,
biochemical, physiological, exposure, and behavioral levels, particularly with regard to disease processes and
treatment response, according to research investigations that have applied data-intensive biomedical technology.
This implies that it is frequently necessary to "personalise" or "tailor" medications to the complex and frequently
distinctive characteristics held by certain individuals. AI can play a significant role in the development of
personalised medicines at all pertinent stages of the clinical development and implementation of new personalised
health products, from finding appropriate intervention targets to testing them for their utility.This is because data-
intensive assays are crucial to revealing appropriate intervention targets and strategies for personalising medicines.
They outlined various areas where AI can contribute to the creation of personalised medicines and made the case
that the development of pertinent assays and techniques for storing, aggregating, accessing, and ultimately
integrating the data they generate will be crucial to AI's ability to advance personalised medicine.
Tim Hulsen et al. (2022) says the simulation of human intelligence in machines through the use of machine learning
(ML), deep learning (DL), and neural networks (NNs) is known as artificial intelligence (AI). AI enables machines
to learn from experience and carry out jobs that humans would carry out. 'Big data' and rising processing power have
accelerated the area of AI research's development during the last five to ten years. AI can be applied in the medical
1113
ISSN: 2320-5407 Int. J. Adv. Res. 11(09), 1112-1115
field to enhance diagnosis, prognosis, treatment, surgery, drug development, and other processes.So, there is a lot of
investment in AI coming from both academia and business. This review looks at bibliographical data, trends through
time, and keyword occurrences to investigate the biomedical literature (in the PubMed and Embase databases).
Observations are made, including: over the past few years, AI has grown exponentially; it is primarily used for
diagnosis; COVID-19 is already among the top three diseases studied using AI; China, the United States, South
Korea, the United Kingdom, and Canada publish the most articles in AI research; Stanford University is the top
institution for AI study worldwide; and convolutional NNs are currently by far the most widely used deep learning
algorithms.By examining more literature databases or including patent databases, these trends could be examined in
greater detail. The future course of AI development could be predicted using more sophisticated studies. In spite of
stronger privacy rules, a greater need for standardisation, bias in the data, and the requirement to establish trust, it is
anticipated that AI will continue to advance.
Nitesh Naik et al. (2022) present Privacy and surveillance, bias or discrimination, as well as the potential
philosophical conundrum of the function of human judgement, are among the legal and ethical problems that
artificial intelligence (AI) has brought to society. The introduction of modern digital technologies has given rise to
worries that they may become a new source of inaccuracy and data breaches. In the sphere of healthcare, errors in
process or protocol can have disastrous repercussions for the patient who is the victim of the error.It is important to
keep in mind that patients interact with doctors during times in their lives when they are most vulnerable. The
application of artificial intelligence in healthcare settings may give rise to legal and ethical problems, but there are
currently no clear regulations in place to handle them. This analysis makes an effort to address these important
challenges, emphasising the necessity of algorithmic openness, privacy, and protection for all connected
beneficiaries as well as cybersecurity for related vulnerabilities.
Conclusion:-
Finally, the rapid development of artificial intelligence (AI) technologies such as machine learning, natural language
processing, and computer vision has ushered in a new era of innovation across a wide range of fields. AI's potential
in the healthcare sector is apparent, with a plethora of options to improve patient care, diagnostics, personalised
therapy, and medical research. This study has examined some significant areas of artificial intelligence's impact on
healthcare:
1. Diagnostic Accuracy
2. Treatment Optimization and Personalized Medicine
3. Patient Management and Predictive Analysis
4. Medical Research and Literature Analysis
Despite the enormous promise of AI in healthcare, a number of difficulties and ethical issues need to be resolved.
These concerns range from maintaining openness and trust in AI-driven judgments to problems with algorithmic
bias, patient acceptability, regulatory compliance, and data protection.
In summary, the introduction of AI into the healthcare sector heralds a paradigm shift for the sector. Though
technology has fantastic prospects for advancing patient care and medical research, it also presents ethical and
regulatory obstacles that must be carefully navigated. Healthcare AI holds great promise for the future, and as
technology develops, it is crucial that all parties collaborate to ensure its ethical and responsible deployment while
putting the needs of patients and the equitable provision of healthcare services first.
References:-
1. Hulsen T. (2022). Literature analysis of artificial intelligence in biomedicine. Annals of translational medicine,
10(23), 1284. https://doi.org/10.21037/atm-2022-50
1114
ISSN: 2320-5407 Int. J. Adv. Res. 11(09), 1112-1115
2. Krishnamurthy, R., Mummudi, N., Goda, J. S., Chopra, S., Heijmen, B., &Swamidas, J. (2022). Using Artificial
Intelligence for Optimization of the Processes and Resource Utilization in Radiotherapy. JCO global oncology,
8, e2100393. https://doi.org/10.1200/GO.21.00393
3. Naik, N., Hameed, B. M. Z., Shetty, D. K., Swain, D., Shah, M., Paul, R., et al. (2022). Legal and ethical
consideration in artificial intelligence in Healthcare: Who takes responsibility? Frontiers. Available at:
https://www.frontiersin.org/articles/10.3389/fsurg.2022.862322/full [Accessed September 5, 2023].1
4. Phillips, S. P., Spithoff, S., & Simpson, A. (2022). Artificial intelligence and predictive algorithms in medicine:
Promise and problems. Canadian family physician Medecin de famillecanadien, 68(8), 570–572.
https://doi.org/10.46747/cfp.6808570
5. Schork N. J. (2019). Artificial Intelligence and Personalized Medicine. Cancer treatment and research, 178,
265–283. https://doi.org/10.1007/978-3-030-16391-4_11
6. Waller, J., O'Connor, A., Rafaat, E., Amireh, A., Dempsey, J., Martin, C., & Umair, M. (2022). Applications
and challenges of artificial intelligence in diagnostic and interventional radiology. Polish journal of radiology,
87, e113–e117. https://doi.org/10.5114/pjr.2022.113531.
1115